NeuroPace reiterates $98M–$100M 2026 revenue target while advancing AI and IGE pipeline [Seeking Alpha]
Neuropace, Inc. (NPCE)
Company Research
Source: Seeking Alpha
Joel Becker, CEO, reported "strong quarterly revenue of $26.6 million, representing 24% year-over-year growth" and highlighted that RNS System revenue reached "$22.4 million, up 26% year-over-year." Becker emphasized the company is "deepening adoption and utilization within our current adult focal epilepsy indication and Fresh Stock Ideas, Every Day Explore diverse investing perspectives with daily analysis from experts across the market. Subscribe to Stock Ideas Sign Up Quick Insights NeuroPace delivered strong quarter-over-quarter and year-over-year revenue growth, maintained high gross margins, and improved adjusted EBITDA, indicating positive financial performance in its core RNS business. Key growth drivers include deepening adoption of the RNS System in focal epilepsy, potential FDA approval for IGE indication, expansions in commercial infrastructure, clinical development of AI-enabled products like Seizure ID, and pursuing payer coverage expansion. Risks includ
Show less
Read more
Impact Snapshot
Event Time:
NPCE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NPCE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NPCE alerts
High impacting Neuropace, Inc. news events
Weekly update
A roundup of the hottest topics
NPCE
News
- NeuroPace to Present at the Leerink Global Healthcare ConferenceBusiness Wire
- NeuroPace (NPCE) was upgraded by Cantor Fitzgerald to "strong-buy".MarketBeat
- Why NeuroPace Stock Was Inching Higher on Wednesday [Yahoo! Finance]Yahoo! Finance
- NeuroPace Inc (NPCE) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]Yahoo! Finance
- NeuroPace, Inc. (NPCE) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
NPCE
Earnings
- 3/3/26 - Beat
NPCE
Sec Filings
- 3/4/26 - Form 4
- 3/4/26 - Form 4
- 3/3/26 - Form S-8
- NPCE's page on the SEC website